Zhi Yao Selected Research

Protein Isoforms (Isoforms)

11/2018	Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells.
9/2013	Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells.
7/2013	Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi Yao Research Topics

Disease

85	Neoplasms (Cancer) 05/2024 - 11/2003
34	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2003
24	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2007
19	Inflammation (Inflammations) 12/2023 - 09/2006
17	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 04/2004
16	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 06/2003
12	Infections 03/2024 - 03/2005
10	Lung Neoplasms (Lung Cancer) 11/2018 - 09/2005
8	Carcinogenesis 01/2022 - 05/2011
8	Hypothyroidism 05/2021 - 01/2015
8	Carcinoma (Carcinomatosis) 11/2012 - 01/2006
7	Melanoma (Melanoma, Malignant) 04/2024 - 01/2006
7	Insulin Resistance 12/2020 - 12/2007
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 03/2013
6	Ovarian Neoplasms (Ovarian Cancer) 08/2023 - 07/2009
6	Fibrosis (Cirrhosis) 01/2020 - 10/2008
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 01/2016
6	Multiple Sclerosis 01/2019 - 03/2013
5	Parkinson Disease (Parkinson's Disease) 11/2022 - 03/2009
5	Hypoxia (Hypoxemia) 01/2020 - 12/2011
5	Leukemia 06/2017 - 04/2007
5	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 03/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 07/2014
4	Body Weight (Weight, Body) 12/2020 - 02/2004
4	Liver Neoplasms (Liver Cancer) 01/2018 - 11/2008
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 09/2009
4	Ovarian Epithelial Carcinoma 06/2009 - 10/2005
3	Cytomegalovirus Infections (Inclusion Disease) 01/2024 - 08/2006
3	Colitis 11/2023 - 01/2022
3	Necrosis 01/2023 - 10/2005
3	Wounds and Injuries (Trauma) 11/2022 - 01/2017
3	Experimental Melanoma 01/2021 - 04/2007
3	Thyroiditis 09/2020 - 01/2017
3	Obesity 01/2020 - 12/2011
2	Urinary Tract Infections (Urinary Tract Infection) 03/2024 - 01/2018
2	Bone Resorption 03/2024 - 04/2007
2	Fatigue 01/2024 - 07/2008

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2003
11	CytokinesIBA 01/2024 - 02/2004
11	Messenger RNA (mRNA)IBA 11/2018 - 06/2004
10	Therapeutic UsesIBA 01/2022 - 01/2006
10	tripeptide tyroservatideIBA 01/2016 - 01/2006
9	CateninsIBA 01/2020 - 02/2012
9	H-Tyr-Ser-Leu-OHIBA 01/2018 - 10/2005
8	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 12/2007
8	Interleukin-6 (Interleukin 6)IBA 01/2020 - 02/2004
8	Peptides (Polypeptides)IBA 01/2016 - 07/2008
7	LigandsIBA 04/2024 - 11/2003
7	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2010
6	Interleukin-17 (Interleukin 17)IBA 05/2020 - 11/2009
6	Conditioned Culture MediaIBA 01/2018 - 09/2005
5	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2021 - 06/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
5	Small Interfering RNA (siRNA)IBA 12/2020 - 03/2012
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2004
5	Long Noncoding RNAIBA 01/2020 - 07/2016
5	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2010
5	ChemokinesIBA 07/2016 - 06/2007
5	Interleukin-8 (Interleukin 8)IBA 09/2015 - 10/2005
5	Phosphatidylethanolamine Binding ProteinIBA 07/2009 - 06/2003
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2022
4	Dopamine (Intropin)FDA LinkGeneric 05/2023 - 01/2012
4	CalciumIBA 11/2022 - 10/2005
4	HomocysteineIBA 05/2021 - 01/2015
4	Estrogens (Estrogen)FDA Link 12/2015 - 10/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 11/2003
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2014 - 09/2006
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2009 - 09/2005
3	EnzymesIBA 04/2024 - 07/2008
3	Caspase 3 (Caspase-3)IBA 01/2024 - 12/2013
3	Dextran SulfateIBA 11/2023 - 01/2022
3	Indicators and Reagents (Reagents)IBA 11/2023 - 06/2011
3	CollagenIBA 08/2023 - 09/2013
3	Adenosine (Adenocard)FDA LinkGeneric 03/2022 - 01/2022
3	Amino Acids FDA Link 01/2022 - 01/2006
3	Phosphotransferases (Kinase)IBA 01/2021 - 02/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020 - 01/2015
3	AntibodiesIBA 09/2020 - 06/2017
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 11/2014
3	cytotoxic necrotizing factor type 1IBA 01/2020 - 10/2017
3	Protein Isoforms (Isoforms)IBA 11/2018 - 07/2013
3	Cadherins (E-Cadherin)IBA 01/2017 - 03/2011
3	AdiponectinIBA 01/2017 - 07/2014
3	Interleukin-4 (Interleukin 4)IBA 12/2015 - 02/2011
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2014 - 06/2003
3	Histones (Histone)IBA 01/2011 - 03/2006
3	RANK LigandIBA 04/2007 - 11/2003
3	Prostate-Specific Antigen (Semenogelase)IBA 03/2006 - 11/2003
2	GlucocorticoidsIBA 03/2024 - 01/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 01/2019
2	Hematoxylin (Haematoxylon)IBA 01/2024 - 01/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2023 - 01/2020

Therapy/Procedure

19	Therapeutics 01/2023 - 01/2006
8	Immunotherapy 05/2024 - 11/2011
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2008
5	Liver Transplantation 01/2024 - 08/2006
3	Radiotherapy 01/2020 - 07/2015
3	Intraperitoneal Injections 11/2008 - 02/2004
2	Electrodes (Electrode) 01/2024 - 01/2022